DTC Act of 2025

Senate Bill

S. 229

119th Congress

DTC Act of 2025

In Committee

Introduced:Jan 23, 2025

Primary Sponsor

Richard Durbin

D - IL

Cosponsors

9

Quick Stats

Policy Area

Health

Summary

The DTC Act requires prescription drug advertisements to disclose the wholesale price for a 30-day supply if the drug costs 35 dollars or more monthly. Violations face civil penalties up to 100,000 dollars per occurrence.

Latest Action

Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

AI Summary

Plain-English explanation of this bill

The DTC Act requires prescription drug advertisements to disclose the wholesale price for a 30-day supply if the drug costs 35 dollars or more monthly. Violations face civil penalties up to 100,000 dollars per occurrence.

Last updated: 1/5/2026

Official Summary

Congressional Research Service summary

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025 This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply. Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Key Points

Main provisions of the bill

Requires drug price disclosure in ads
Shows wholesale price for 30-day supply
Applies to drugs over 35 dollars monthly
Covers Medicare and Medicaid drugs
Imposes 100,000 dollar penalty for violations

How This Impacts Americans

Potential effects on citizens and communities

Consumers would see drug prices directly in advertisements. Pharmaceutical companies would face transparency requirements. Drug pricing information would be more accessible to patients before prescriptions.

Policy Areas

Primary Policy Area

Health

Related Subjects

Administrative law and regulatory procedures

Civil actions and liability

Department of Health and Human Services

Health care costs and insurance

Marketing and advertising

Prescription drugs

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

229, 119th Congress (2025). "DTC Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-s-229